Markets News

Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.

Webster Trading Volume Surges 20-Fold as Santander Merger Nears Close
Markets Daniel Marsh

Webster Trading Volume Surges 20-Fold as Santander Merger Nears Close

Webster Financial's stock traded at 19.7 times its usual volume on Wednesday as the Santander merger nears its final day. The deal spread remains tight at 0.38%.

WBS SAN
Boeing Stock Slips 0.5% as Netflix Documentary Raises Safety Questions
Markets Daniel Marsh

Boeing Stock Slips 0.5% as Netflix Documentary Raises Safety Questions

Boeing shares dipped 0.5% on Wednesday following the release of a critical Netflix documentary, but a record $715B backlog and solid Q2 earnings tempered the selloff.

BA NFLX
Aramco's $224B Upside Hinges on Hormuz Bypass as Saudi Market Halts
Markets Daniel Marsh

Aramco's $224B Upside Hinges on Hormuz Bypass as Saudi Market Halts

Saudi Exchange halted, Aramco flat at SAR 26.64. Analysts see 13% upside, $224B value, tied to East-West pipeline amid Hormuz risks.

MRK Surges 13% on Cancer Vaccine Data, Market Cap Jumps $44B
Markets Daniel Marsh

MRK Surges 13% on Cancer Vaccine Data, Market Cap Jumps $44B

Merck (MRK) shares soared 13.3% to $153.12 after promising Phase 3 data for its melanoma vaccine with Moderna (MRNA), boosting market cap by $44.4B.

MRK MRNA
S&P 500 Recovers Most of Tuesday's Loss, Healthcare Leads as Tech Lags
Markets Daniel Marsh

S&P 500 Recovers Most of Tuesday's Loss, Healthcare Leads as Tech Lags

The S&P 500 bounced back on Wednesday, recovering most of Tuesday's decline, but leadership shifted to healthcare as technology remained flat.

SPY MRNA MRK AVGO MRVL GOOGL C JPM GS UBS
Fed Minutes Signal More Hikes, but Treasury Buybacks Mute Long-End Reaction
Markets Daniel Marsh

Fed Minutes Signal More Hikes, but Treasury Buybacks Mute Long-End Reaction

Fed minutes show wider backing for a July hike, but Treasury buybacks keep long yields in check. Two-year yield barely moves while 30-year falls.

TLT GLD SPY QQQ
Salesforce Stock Surges 4.9% on JPMorgan's Bullish $250 Target
Markets Daniel Marsh

Salesforce Stock Surges 4.9% on JPMorgan's Bullish $250 Target

Salesforce (CRM) climbed 4.9% to $205.65 after JPMorgan set a $250 price target, implying 22% upside. The rally highlights optimism, but fiscal 2027 organic growth and margin targets remain a key focus.

CRM MRK ADBE SAP ORCL WDAY
Chip ETF Slips as Marvell-Broadcom Deal Talks Collapse
Markets Daniel Marsh

Chip ETF Slips as Marvell-Broadcom Deal Talks Collapse

The VanEck Semiconductor ETF (SMH) dropped 1.2% after Marvell and Broadcom ended merger talks, triggering a broader chip selloff despite gains in the S&P 500.

SMH SOXX QQQ MRVL AVGO AMD MU NVDA TSM
Lumentum Stock Slides on Capacity Concerns Despite Strong AI Demand
Markets Daniel Marsh

Lumentum Stock Slides on Capacity Concerns Despite Strong AI Demand

Lumentum shares dropped 3.9% as investors focus on capacity challenges despite a 24% revenue growth forecast and strong AI-driven demand.

LITE COHR AAOI SPY NVDA
Treasury Doubles Long-Duration Buybacks; TLT Rallies 1.6%
Markets Daniel Marsh

Treasury Doubles Long-Duration Buybacks; TLT Rallies 1.6%

TLT rallied 1.6% after Treasury doubled long-dated buybacks, but duration risk remains the dominant factor. The move offers temporary relief, not a trend reversal.

TLT
Broadcom Slips as Google Expands Chip Supplier Roster Amid $370B AI Financing
Markets Daniel Marsh

Broadcom Slips as Google Expands Chip Supplier Roster Amid $370B AI Financing

Broadcom shares dropped 2% premarket after Google expanded its custom-chip suppliers to include Marvell, while a $370B AI financing estimate highlights scale and competition.

AVGO MRVL GOOGL APO BX
Nebius Plunges 11% on $4.5B Convertible Note Sale
Markets Daniel Marsh

Nebius Plunges 11% on $4.5B Convertible Note Sale

Nebius shares dropped 10.8% after a $4.5B convertible note offering, covering 80% of quarterly AI infrastructure spend. Analysts see 24% upside.

NBIS CRWV NVDA